BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27389386)

  • 1. Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Balassa K; Krahling T; Remenyi P; Batai A; Bors A; Kiss KP; Torbagyi E; Gopcsa L; Lengyel L; Barta A; Varga G; Tordai A; Masszi T; Andrikovics H
    Leuk Lymphoma; 2017 Feb; 58(2):391-398. PubMed ID: 27389386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
    Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Kosmaczewska A; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Ciszak L; Jagoda K; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunol Lett; 2015 May; 165(1):52-9. PubMed ID: 25841352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation.
    Eefting M; von dem Borne PA; de Wreede LC; Halkes CJ; Kersting S; Marijt EW; Veelken H; Falkenburg JF
    Haematologica; 2014 Apr; 99(4):751-8. PubMed ID: 24241493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
    Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
    Front Immunol; 2020; 11():1534. PubMed ID: 32849519
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Cho IH; Song YK; Kim MG; Han N; Kim T; Oh JM
    Hematology; 2015 Apr; 20(3):121-8. PubMed ID: 25116082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allogeneic stem cell transplantation for 75 cases of acute myeloid leukemia in complete remission: outcome and prognostic analysis].
    Song AX; Yang DL; Wei JL; Yan ZS; Wang M; Jiang EL; Huang Y; Liu QG; Ma QL; Zhai WH; Zhang RL; Feng SZ; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):161-6. PubMed ID: 20137139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analyses of risk factors for intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Yan FH; Wang M; Huang Y; Jiang EL; Ma QL; Wei JL; Pang AM; Zhang RL; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1020-3. PubMed ID: 24369157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
    Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
    Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remission: a retrospective study.
    Nasilowska-Adamska B; Czyz A; Markiewicz M; Rzepecki P; Piatkowska-Jakubas B; Paluszewska M; Dzierzak-Mietla M; Solarska I; Borg K; Prochorec-Sobieszek M; Szydlo R; Lewandowski K; Skotnicki A; Jedrzejczak WW; Kyrcz-Krzemien S; Komarnicki M; Warzocha K
    Eur J Haematol; 2016 Mar; 96(3):236-44. PubMed ID: 25912052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between IL1B (+3954) polymorphisms and IL-1β levels in blood and saliva, together with acute graft-versus-host disease.
    Resende RG; Abreu MH; de Souza LN; Silva ME; Gomez RS; Correia-Silva Jde F
    J Interferon Cytokine Res; 2013 Jul; 33(7):392-7. PubMed ID: 23659674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    Eur J Haematol; 2019 Mar; 102(3):251-255. PubMed ID: 30465728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Socié G; Loiseau P; Tamouza R; Janin A; Busson M; Gluckman E; Charron D
    Transplantation; 2001 Aug; 72(4):699-706. PubMed ID: 11544434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept study.
    Han H; Yuan F; Sun Y; Liu J; Liu S; Luo Y; Liang F; Liu N; Long J; Zhao X; Kong F; Xi Y
    Oncotarget; 2015 Nov; 6(37):40337-59. PubMed ID: 26498683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch on glutathione S-transferase T1 increases the risk of graft-versus-host disease and mortality after allogeneic stem cell transplantation.
    Martínez-Bravo MJ; Calderón-Cabrera C; Márquez-Malaver FJ; Rodríguez N; Guijarro M; Espigado I; Núñez-Roldán A; Pérez-Simón JA; Aguilera I
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1356-62. PubMed ID: 24844856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
    Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.